crdl stock price target

The 4 analysts offering 12-month price forecasts for Cardiol Therapeutics Inc have a median target of 582 with a high estimate of 876 and a low estimate of 311. 25 Raymond James raised the target price for CRDL stock to.

Crdl Cardiol Therapeutics Due Diligence Research Analysis R Fluentinfinance

Each analysts rating is normalized to a standardized rating score of 1 sell 2 hold 3 buy or 4 strong buy.

. Analyst ratings historical stock prices earnings estimates actuals. Analyst estimates including CRDL earnings per share estimates and analyst recommendations. The 2 analysts offering price forecasts for Cardiol Therapeutics have a median target of 800 with a high estimate of 800 and a low estimate of 800.

Analyst Price Target on CRDL. Based on analysts offering 12 month price targets for CRDL in the last 3 months. View real-time CRDL stock price and news along with industry-best analysis.

View todays CRDL stock price trade commission-free and discuss CRDL stock updates with the investor community. According to the issued ratings of 3 analysts in the last year the consensus rating for Cardiol Therapeutics stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for CRDL. Find A Dedicated Financial Advisor.

2 Wall Street analysts that have issued a 1 year CRDL price target the average CRDL price target is 800 with the highest CRDL stock price forecast at 800 and the lowest CRDL stock price forecast at 800On average Wall Street analysts predict. The average price target is 000 with a high estimate of 000 and a low estimate of 000. CRDL updated stock price target summary.

Stock news by MarketWatch. Stock information by Barrons. Cardiol Therapeutics Inc.

Visit The Official Edward Jones Site. USD 136 015 993. CRDLCA updated stock price target summary.

Analyst Price Target for CRDL i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. The consensus target price for the stock is 5 which implies an upside potential of 225 percent from the current price levels.

The average twelve-month price prediction for Cardiol Therapeutics is C633 with a high price target of C800 and a low price target of C400. New Look At Your Financial Strategy. View real-time stock prices and stock quotes for a full financial overview.

30602 Upside Based on 1 Wall Street analysts offering 12 month price targets for Cardiol Therapeutics in the last 3 months. Average price target from 4 ratings. The median estimate represents a 1950.

The value that each share actually gained. A high-level overview of Cardiol Therapeutics Inc. Analyst ratings historical stock prices earnings estimates actuals.

Get Cardiol Therapeutics Inc CRDLNASDAQ real-time stock quotes news price and financial information from CNBC. CRDL - USA Stock. According to the issued ratings of 3 analysts in the last year the consensus rating for Cardiol Therapeutics stock is Buy based on the current 3 buy ratings for CRDL.

Complete Cardiol Therapeutics Inc. Cardiol Therapeutics stock price prediction is an act of determining the future value of Cardiol Therapeutics shares using few different conventional methods such as EPS estimation. That CARDIOL THERAPEUTICSs share price could reach 800 by Dec 17 2022.

The average twelve-month price prediction for Cardiol Therapeutics is 750 with a high price target of 800 and a low price target of 700. Real time Cardiol Therapeutics Inc. Analyst Price Target for CRDL i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.

The average price target is 540 with a high forecast of 540 and a low forecast of 540. According to 10 analysts the average rating for CRDL stock is Buy The 12-month stock price forecast is 821 which is an increase of 49065 from the latest price. CRDL stock price quote stock graph news analysis.

The average price target represents a 30602 change from the last price of 133. Lets Partner Through All Of It. Find the latest CARDIOL THERAPEUTICS INC CRDLTO analyst stock forecast price target and recommendation trends with in-depth analysis from research.

Life Is For Living. Cardiol Therapeutics Inc. Zacks proprietary data indicates that Cardiol Therapeutics Inc.

Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CRDL shares. The value each share was expected to gain vs. Each analysts rating is normalized to a standardized rating.

Looking to buy Cardiol Therapeutics stock. Learn more on CRDLs analyst rating. CRDL Complete Cardiol Therapeutics Inc.

Crdl Price Target 2022 Analyst Ratings Predictions Cardiol Therapeutics